PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | |hypertension |
| Sentences | 72 |
| PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
| PubMedID- 21506350 | An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development. |
| PubMedID- 22114590 | We have a long-lasting interest in applying endoscopic ultrasound for the study of features of portal hypertension in patients with liver cirrhosis [2, 3, 11, 21]. |
| PubMedID- 21994879 | In our two cases, the patients' risk factors included portal hypertension due to liver cirrhosis, and previous surgery. |
| PubMedID- 23909264 | Results: hepatic vein catheterisation is reliable for assessing the portal hypertension in the group of patients with liver cirrhosis of ethylic etiology. |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding [16]. |
| PubMedID- 23559324 | Olt was performed at the age of 7 years, due to liver cirrhosis with portal hypertension, in the absence of neurological lesions and an almost-normal brain mri. |
| PubMedID- 25888771 | A 56-year-old chinese man with a history of portal hypertension due to hbv-related liver cirrhosis and known former recurrent esophageal varices bleeding status post sengstaken-blakemore tube tamponade was referred to our hospital for liver transplantation evaluation because of persistent ev bleeding with hypovolemic shock, even after medical and endoscopic therapies in a local hospital. |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 20652243 | Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24974920 | So, the current study was conducted to evaluate cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension by conventional doppler echocardiography and tdi. |
| PubMedID- 20698946 | Varices of the colon are a rare cause of lower gastrointestinal bleed, usually associated with portal hypertension due to liver cirrhosis or other causes of portal venous obstruction. |
| PubMedID- 25656015 | [case report : bleeding from ileal conduit in a patient with portal hypertension due to liver cirrhosis type c]. |
| PubMedID- 25812120 | In some patients liver fibrosis leads to liver cirrhosis with portal hypertension, hepatocellular dysfunction and increased risk of hepatocellular carcinoma [2,3]. |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23922700 | Portal hypertension, a major complication of liver cirrhosis, can cause lethal complications, such as gastroesophageal variceal hemorrhage, ascites, hepatorenal syndrome and hepatic encephalopathy [1]. |
| PubMedID- 23787475 | Oct is a somatostatin analogue that has few side effects, and its injection is clinically used for lowering the portal hypertension associated with liver cirrhosis [5]. |
| PubMedID- 23964340 | This is because duodenal varices are located deep in the serosal layer, while esophageal varices are located in the submucosal area.3 the most common cause (30%) of duodenal varices is portal hypertension due to liver cirrhosis. |
| PubMedID- 24812632 | Therefore, intervention of this signaling pathway (particularly inhibition of tgf-β1 levels) may be an important target for the prevention and treatment of portal hypertension due to liver cirrhosis. |
| PubMedID- 25374728 | Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23984413 | Spleen stiffness, but not liver stiffness, was positively correlated with the presence of ascites as a representative marker of portal hypertension in patients with liver cirrhosis and the spleen stiffness did not correlate with the presence of esophageal varices in chronic hepatitis c patients. |
| PubMedID- 24729881 | 17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > uln to 1.5 × uln or ast/alt > uln to 2.5 × uln) and 1 patient additional liver cirrhosis with portal hypertension (score 3). |
| PubMedID- 23326153 | The transjugular intrahepatic portosystemic shunt (tips) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. |
| PubMedID- 25933224 | liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin [3], which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow. |
| PubMedID- 22009385 | Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc). |
| PubMedID- 23248978 | Conclusions: we concluded that being only slightly invasive, the sandwich strategy treatment of ls with pd and lps is feasible, effective, and safe for patients with portal hypertension due to liver cirrhosis. |
| PubMedID- 26357501 | The presence of ascites is one of complications of portal hypertension due to advanced liver cirrhosis. |
| PubMedID- 24757655 | Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis. |
| PubMedID- 25798930 | Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc). |
| PubMedID- 25701619 | Objective: we have compared the influences of three surgical strategies on the occurrence and development of portal vein thrombosis (pvt) in patients with liver cirrhosis complicated by portal hypertension (pht) in this study. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 22591184 | Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23801819 | Subsequent investigations revealed the presence of hepatitis b with secondary liver cirrhosis, complicated by portal hypertension and esophageal varices. |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis [1,2]. |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 24331694 | [non-invasive assessment of portal hypertension in patients with liver cirrhosis using fibroscan transient elastography]. |
| PubMedID- 24574834 | Variceal bleeding is one of the most fatal complications of portal hypertension in patients with liver cirrhosis [2,17]. |
| PubMedID- 24400086 | The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure. |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22957328 | Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23403613 | The only inclusion criterion was the presence of clinical portal hypertension with intrinsic liver cirrhosis. |
| PubMedID- 24775062 | Pathology such as myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or antithrombin iii as well as hepatocellular carcinoma also could contribute to pvt. |
| PubMedID- 21606920 | The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed. |
| PubMedID- 23586850 | Reported a 29% in-hospital mortality after colorectal surgery among patients with liver cirrhosis complicated by portal hypertension and 14% in patients with compensated liver cirrhosis [10]. |
| PubMedID- 22629430 | The pre-existing diseases studied here included hypertension, diabetes, chf, history of stroke, liver cirrhosis, cancer, heart disease, gastrointestinal diseases, and some lung diseases, such as copd, chronic bronchitis, pulmonary emphysema, and asthma. |
| PubMedID- 23346104 | Ninety liver cirrhosis patients with postal hypertension and ascites (grade b, c acc. |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 25120838 | One of the most prevalent non-neoplastic causes is portal hypertension mostly due to liver cirrhosis. |
Page: 1 2